Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion

Watch Paul and Scarlet LIVE every day on YouTube: http://bit.ly/3vTiACF.Bloomberg Intelligence hosted by Paul Sweeney, Alexis Christoforous, and Stacey Vanek Smith-Madison Muller, Bloomberg News Health Reporter, discusses news that Eli Lilly & Co. is buying three clinical-stage vaccine developers for as much as $3.8 billion to establish itself as a leader in other areas and become a major player in infectious diseases.-Anthony Hughes, Bloomberg US Equity Capital Markets Reporter, discusses Quantinuum seeking to raise $1.05 billion in its US initial public offering, capitalizing on investor enthusiasm for quantum computing technology.-Craig Trudell, Bloomberg Managing Editor of Global Business Coverage, discusses Ferrari shares falling almost 8% after critics panned the look of its first fully electric vehicle, a setback for the Italian super-car maker’s controversial push into EVs.-Jennifer Bartashus, Bloomberg Intelligence Senior Analyst, Retail Staples & Packaged Food, discusses research: "World Cup's $80 Billion Prize Hinges on Fans Not Crying Foul." FIFA's nearly $9 billion expected revenue take from this year's World Cup may understate the tournament's broader economic impact, with US legal betting alone set to top $2 billion, based on Bloomberg Intelligence's analysis.See omnystudio.com/listener for privacy information.